Clinical Study of Therapeutic Angiogenesis Using Hypoxic Preconditioned Peripheral Blood Mononuclear Cells
- Conditions
- Peripheral arterial occlusive disease
- Registration Number
- JPRN-UMIN000018594
- Lead Sponsor
- Yamaguchi University Graduate School of Medicine Department of Surgery and Clinical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 7
Not provided
1. Patients suffering from bacterial infections such as treponema palladium, chlamydia, gonorrhea and tuberculosis. 2. Patients suffering from infections such as hepatitis B and C viruses, human immunodeficiency virus, human T lymphotropic virus type 1 and parvovirus B19. 3. Patients with sepsis or suspected with. 4. Patients with malignant neoplasm or history of malignant neoplasm treatmented within five years. 5. Patients with serious endocrine disorders such as uncontrolled thyroid disfunction. 6. Patients with blood disorders except for chronic kidney disease. 7. Patients with liver disease with Child-Pugh classification B or more. 8. Patients with transmissible spongiform encephalopathy or suspected with. 9. Patients with dementia with a a revised version Hasegawa dementia scale score smaller than 4. 10. Patient determined to be ineligible for this clinical study by research attending physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence and severity of the adverse events
- Secondary Outcome Measures
Name Time Method